OBGYN EHR Industry

The global OBGYN electronic health records (EHR) market is projected to reach USD 3.3 billion by 2030, expanding at a CAGR of 9.50% from 2023 to 2030, according to Grand View Research, Inc. This growth is fueled by the rising adoption of specialty-specific EHR systems, government incentives, and the need for streamlined clinical workflows in gynecology and obstetrics practices.

Key Growth Drivers

Rising Adoption of EHRs in Women’s Health
Growing need for data integration, billing, e-prescribing, clinical documentation, and practice management is pushing gynecologists and obstetricians toward EHR platforms.
EHRs tailored for OBGYN improve workflow efficiency, enhance patient engagement, and reduce administrative burdens.

Government Initiatives & Regulatory Support
In the U.S., the HITECH Act offers financial incentives for meaningful EHR use.
The UK’s NHS has committed USD 2.4 billion to digitize health records across community practices and hospitals.
These supportive initiatives are accelerating EHR adoption globally.

Product Innovation
Companies are introducing specialty-focused platforms, such as WRS Health’s ObGyn-Cloud (launched in July 2019), to meet specific workflow and compliance needs of obstetricians and gynecologists.

Market Challenges

Impact of COVID-19
The pandemic caused delays and cancellations in EHR software purchases and new projects.
Reduced hospital revenues and lower patient volumes led to a temporary dip in digital health investments.

Trends to Watch

Shift toward value-based care is creating demand for integrated digital tools to improve outcomes and reduce costs

Growing interest in cloud-based EHR systems for scalability and remote access

Increased focus on patient data security, interoperability, and telehealth integration

Curious about the OBGYN EHR Market, Download your FREE sample copy now and get a sneak peek into the latest insights and trends.

OBGYN EHR Market Segments Highlights:

1. Based on the product, the web-based EHR dominated the market in 2022. This can be attributed to the high demand for web-based solutions among physicians

2. In terms of applications, the workflow management segment accounted for a major portion of the market in 2022. Electronic health records streamline the complex process of gynecology practices, thereby fueling the segment growth

3. The billing segment is anticipated to witness lucrative growth during the forecast period owing to the increasing integration of RCM solutions with electronic health records

4. North America dominated the market in 2022 mainly due to strong government support and the strategic presence of key providers

5. Asia Pacific is expected to report the fastest growth from 2023 to 2030 due to the growing number of OB-GYN practices in the region and significant developments in healthcare IT infrastructure

OBGYN EHR Market Report Segmentation

Grand View Research has segmented the global OBGYN EHR market on the basis of product, application, and region:

OBGYN EHR Product Outlook (Revenue, USD Million, 2018 - 2030)

1. Client Server-based EHR

2. Web-based EHR

OBGYN EHR Application Outlook (Revenue, USD Million, 2018 - 2030)

1. Scheduling

2. Billing

3. Clinical Documentation

4. Workflow Management

5. Others

OBGYN EHR Regional Outlook (Revenue, USD Million, 2018 - 2030)

1. North America

   1. US

   2. Canada

2. Europe

   1. UK

   2. Germany

   3. France

   4. Italy

   5. Spain

   6. Denmark

   7. Sweden

   8. Norway

3. Asia Pacific

   1. Japan

   2. China

   3. India

   4. South Korea

   5. Australia

   6. Thailand

4. Latin America

   1. Brazil

   2. Mexico

   3. Argentina

5. Middle East & Africa

   1. South Africa

   2. Saudi Arabia

   3. UAE

   4. Kuwait

Key OBGYN EHR Company Insights

1. InSync Healthcare Solutions

2. Practice Fusion, Inc.

3. WRS Health

4. Bizmatics, Inc.

5. Greenway Health, LLC

6. CureMD Healthcare

7. NXGN Management, LLC

8. Infor-Med Inc.

9. EndoSoft LLC

10. RevenueXL Inc

Order a free sample PDF of the OBGYN EHR Market Intelligence Study, published by Grand View Research.